Principi, E.; Sondo, E.; Bianchi, G.; Ravera, S.; Morini, M.; Tomati, V.; Pastorino, C.; Zara, F.; Bruno, C.; Eva, A.;
et al. Targeting of Ubiquitin E3 Ligase RNF5 as a Novel Therapeutic Strategy in Neuroectodermal Tumors. Cancers 2022, 14, 1802.
https://doi.org/10.3390/cancers14071802
AMA Style
Principi E, Sondo E, Bianchi G, Ravera S, Morini M, Tomati V, Pastorino C, Zara F, Bruno C, Eva A,
et al. Targeting of Ubiquitin E3 Ligase RNF5 as a Novel Therapeutic Strategy in Neuroectodermal Tumors. Cancers. 2022; 14(7):1802.
https://doi.org/10.3390/cancers14071802
Chicago/Turabian Style
Principi, Elisa, Elvira Sondo, Giovanna Bianchi, Silvia Ravera, Martina Morini, Valeria Tomati, Cristina Pastorino, Federico Zara, Claudio Bruno, Alessandra Eva,
and et al. 2022. "Targeting of Ubiquitin E3 Ligase RNF5 as a Novel Therapeutic Strategy in Neuroectodermal Tumors" Cancers 14, no. 7: 1802.
https://doi.org/10.3390/cancers14071802
APA Style
Principi, E., Sondo, E., Bianchi, G., Ravera, S., Morini, M., Tomati, V., Pastorino, C., Zara, F., Bruno, C., Eva, A., Pedemonte, N., & Raffaghello, L.
(2022). Targeting of Ubiquitin E3 Ligase RNF5 as a Novel Therapeutic Strategy in Neuroectodermal Tumors. Cancers, 14(7), 1802.
https://doi.org/10.3390/cancers14071802